Patanjali sought Coronil licence for immunity: U’khand
‘Firm didn’t mention it as Covid cure
Trouble seems to be in store for yoga guru Baba Ramdev on his claim to have developed Coronil — a drug for Covid-19 cure.
The Uttarakhand Government on Wednesday said Patanjali Ayurveda never disclosed that its new medicine kit was for treating the virus when it applied for a licence.
Union AYUSH Minister Shripad Naik too tried to distance himself from the controversy and said it is a “good thing” that Ramdev has given the country a new medicine but it needs proper permission from his Ministry.
“It is a good thing that Baba Ramdev has given a new medicine to the country but as per rules, it has to come to the AYUSH Ministry first. Anyone can make medicines. Anyone who wants to make medicines has to go through the AYUSH Ministry task force. Everyone has to send details of the research to the AYUSH Ministry for confirmation. This is the rule and no can advertise their products without it,” the Minister asserted.
An official from Uttarakhand Government’s Ayurveda Department told news agency ANI, “Patanjali Ayurved had sought licence for immunity booster, cough and fever without mentioning coronavirus in the application. As They didn’t mention coronavirus, we only approved licence for immunity booster, cough and fever.”
On Tuesday, Baba Ramdev’s Patanjali launched the Ayurvedic tablet, “Coronil” claiming that it will help to cure coronavirus infection which has left the world to standstill.
However, later in the day, the Ministry of AYUSH asked the firm to provide details of the drug’s composition and evidence for its findings and trials. “Facts of the claims and details of the stated scientific study are not known to the Ministry,” the Ministry said.
The Government also asked Patanjali not to advertise the product until the issue is examined. While launching the drug, Patanjali had said, “100 per cent Covid-19 patients recover within seven days.”
Dismissing the ongoing controversy, Patanjali Ayurved said the issue is unnecessarily being blown out of proportion.
“All the required documents are in order and the company has also sent a reply to the Ministry. Everything is in order as per the mandated protocol,” Patanjali Ayurved spokesperson SK Tijarawala had said.
The medicines, “Coronil and Swasari”, come in a corona kit priced at Rs 545, which was to be sold across India within a week.
Ramdev claimed Patanjali’s medicines showed “100 per cent favourable results” in clinical trials on 280 patients in Delhi, Ahmedabad and other cities. Patanjali collaborated with the privately-owned National Institute of Medical Sciences or NIMS University, Jaipur.
“With the help of NIMS, Jaipur we conducted the clinical control study on 95 patients. The biggest thing which came out of this is that within three days 69 per cent patients recovered and became negative from positive (cases) and within seven days 100 per cent of them became negative,” Ramdev told reporters.
The Ministry of Ayush has asked Patanjali to provide details like the composition of the medicines, the results of its research, the hospitals where the research was conducted, whether the company had a clearance from the Institutional Ethics Committee and whether it had registered for the clinical trials.
Thursday, 25 June 2020 | PNS | New Delhi
You might also like
- Patanjali sought Coronil licence for immunity: U’khand June 25, 2020
- Nepalis opposing their government’s differences with India: CM June 25, 2020
- 88 found positive for Covid-19 in State on Wednesday June 25, 2020
- Authorities learn of accident victims being Covid positive after cremation June 25, 2020
- South West monsoon advances into entire state June 25, 2020